14-day Premium Trial Subscription Try For FreeTry Free
$0.672
-0.0355 (-5.02%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.631 $0.96 Wednesday, 24th Apr 2024 CARA stock ended at $0.672. This is 5.02% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 8.88% from a day low at $0.661 to a day high of $0.720.
90 days $0.500 $1.15
52 weeks $0.500 $4.67

Historical Cara Therapeutics prices

Date Open High Low Close Volume
Jan 05, 2024 $0.660 $0.660 $0.610 $0.613 911 625
Jan 04, 2024 $0.680 $0.706 $0.640 $0.665 592 492
Jan 03, 2024 $0.80 $0.80 $0.670 $0.682 970 313
Jan 02, 2024 $0.741 $0.82 $0.726 $0.756 915 009
Dec 29, 2023 $0.759 $0.800 $0.712 $0.743 1 368 901
Dec 28, 2023 $0.657 $0.796 $0.657 $0.767 2 267 557
Dec 27, 2023 $0.693 $0.699 $0.620 $0.660 860 978
Dec 26, 2023 $0.654 $0.700 $0.651 $0.690 820 570
Dec 22, 2023 $0.600 $0.681 $0.590 $0.669 1 852 572
Dec 21, 2023 $0.626 $0.626 $0.590 $0.596 952 427
Dec 20, 2023 $0.621 $0.659 $0.580 $0.607 1 358 370
Dec 19, 2023 $0.630 $0.684 $0.600 $0.621 2 230 450
Dec 18, 2023 $1.17 $1.17 $0.570 $0.629 6 403 182
Dec 15, 2023 $1.24 $1.31 $1.21 $1.23 1 222 496
Dec 14, 2023 $1.19 $1.29 $1.17 $1.21 1 098 612
Dec 13, 2023 $1.22 $1.22 $1.10 $1.20 667 760
Dec 12, 2023 $1.19 $1.21 $1.12 $1.21 648 753
Dec 11, 2023 $1.25 $1.25 $1.12 $1.16 609 592
Dec 08, 2023 $1.19 $1.31 $1.19 $1.25 654 695
Dec 07, 2023 $1.10 $1.23 $1.08 $1.20 553 796
Dec 06, 2023 $1.06 $1.16 $1.05 $1.13 485 102
Dec 05, 2023 $1.02 $1.07 $1.02 $1.05 295 355
Dec 04, 2023 $1.03 $1.07 $1.00 $1.02 480 132
Dec 01, 2023 $0.96 $1.10 $0.93 $1.06 588 586
Nov 30, 2023 $1.01 $1.01 $0.93 $0.97 394 183
Click to get the best stock tips daily for free!

About Cara Therapeutics

Cara Therapeutics Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod... CARA Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT